Not Signed In -
Telmisartan and Hydrochlorothiazide |
Micardis HCT |
Clinical Trial: Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
This study is currently recruiting patients.
|
Purpose
A study of two drugs, Lotrel (amlodipine/benazepril) and benazepril/HCTZ, for effectiveness in reducing heart disease and deaths from heart attacks.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Heart Disease | Drug: Lotrel (benazepril/amlodipine) Drug: benazepril plus hydrochlorothiazide | Phase III |
MedlinePlus related topics: Heart Diseases; Heart Diseases--Prevention
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Comparison of the Safety and Effectiveness of Lotrel and Benazapril+HCTZ in Reducing Heart Disease and Heart Attacks
Further Study Details:
Primary Outcomes: Cardiovascular morbidity; Cardiovascular mortality
Expected Total Enrollment: 12600
Expected Total Enrollment: 12600
Study start: October 2003
Eligibility
Ages Eligible for Study: 55 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Adults with high risk hypertension.
- At least 55 years of age.
- Have elevated blood pressure and at least one other cardiovascular disease or diabetes or evidence of damage to the kidneys, brain, blood vessels or heart as defined in the protocol.
Exclusion Criteria:
- Allergy to any of the drugs administered in this trial.
- Selected laboratory tests.
More details provided by the study contact person.
Location and Contact Information
Malcolm Bohm 862-778-6345 malcolm.bohm@pharma.novartis.com
New Jersey
Malcolm Bohm, East Hanover, New Jersey, 07936, United States; Recruiting
More Information
Study ID Numbers: CCIB002I2301
Record last reviewed: December 2004
Last Updated: December 21, 2004
Record first received: November 30, 2004
ClinicalTrials.gov Identifier: NCT00097864
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2004
Last Updated: December 21, 2004
Record first received: November 30, 2004
ClinicalTrials.gov Identifier: NCT00097864
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Micardis HCT (Drug Digest)
- Telmisartan and Hydrochlorothiazide (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
